Journal Name: JACC: CardioOncology
Journal Type: Q1
ISSN: 26660873
Country: United States
Subject Area and Category: Medicine Cardiology and Cardiovascular Medicine Oncology
Publisher: Elsevier Inc.
Research Ranking: 627
Publication Type: Journals
H-Index: 42
Coverage: 2019-2025
Editors-in-Chief: Bonnie Ky, MD, MSCE, FACC
Research Impact Score: 7.6
Impact Factor: 12
SCIMAGO SJR: 2.88
APC Cost: $ 4,200
Submission Link: https://www.jacc.org/journal/cardio-oncology
Contact Email: jaccco@acc.org
Address: Heart House. 2400 N St. NW; Washington, DC 20037;
Overview
JACC: CardioOncology is a leading journal dedicated to the evolving field of cardio-oncology, exploring the complex relationship between cardiovascular diseases and cancer treatments. This emerging interdisciplinary specialty addresses the cardiovascular health challenges faced by cancer patients, particularly those undergoing aggressive therapies like chemotherapy, radiation, and immunotherapy. With an increasing number of cancer survivors, the need for a deeper understanding of cardio-oncology has never been more crucial.
What is Cardio-Oncology?
Cardio-oncology is a subspecialty that focuses on preventing, diagnosing, and managing cardiovascular diseases in cancer patients. Many cancer treatments, such as chemotherapy and radiation, are known to cause cardiovascular complications, which may manifest immediately or in the years following treatment. Cardio-oncologists work closely with oncologists to develop tailored treatment plans that minimize the risk of cardiovascular issues while effectively treating cancer.
JACC: CardioOncology Journal’s Role
The Journal of the American College of Cardiology (JACC): CardioOncology provides a platform for cutting-edge research and clinical studies on cardio-oncology. It features a wide range of articles, from basic science and clinical studies to case reports and reviews, with an emphasis on practical applications for improving patient outcomes. By fostering collaboration between cardiologists and oncologists, the journal plays a vital role in advancing this field of medicine.
Key Topics Covered in JACC: CardioOncology
-
Cardiotoxicity of Cancer Treatments: One of the primary focuses of JACC: CardioOncology is the cardiotoxicity associated with cancer treatments. Research articles explore the mechanisms behind chemotherapy-induced cardiomyopathy, radiation-induced heart disease, and the effects of targeted therapies on the heart. Understanding these mechanisms is essential for developing preventive strategies and managing cardiovascular risks in cancer patients.
-
Early Detection and Monitoring: The journal emphasizes the importance of early detection and monitoring of cardiovascular diseases in cancer patients. Techniques such as echocardiography, electrocardiograms (ECGs), and biomarker testing are highlighted for their role in assessing heart function and identifying cardiovascular risks early.
-
Multidisciplinary Care Approach: JACC: CardioOncology stresses the importance of a collaborative, multidisciplinary approach to care. It underscores how oncologists, cardiologists, and other healthcare providers must work together to optimize patient outcomes. The integration of cardio-oncology into cancer care teams ensures that patients receive comprehensive treatment plans that address both cancer and cardiovascular health.
-
Innovative Therapeutic Strategies: With advancements in both oncology and cardiology, JACC: CardioOncology explores new therapeutic options, including novel pharmacological agents, cardioprotective strategies, and the development of personalized treatment protocols for cancer patients at risk of cardiovascular disease.
-
Long-Term Survivorship: Another critical area of focus is the long-term cardiovascular health of cancer survivors. As survival rates for cancer continue to improve, understanding how to manage the long-term effects of cancer treatments on the heart becomes essential. JACC: CardioOncology addresses strategies for improving the quality of life and heart health for cancer survivors.
About
CardioOncology is a rapidly evolving field that combines the expertise of cardiology and oncology to address the cardiovascular health concerns of cancer patients. With advancements in cancer treatments, particularly chemotherapy and immunotherapy, there has been a significant rise in cardiovascular complications. This has led to the emergence of CardioOncology as a specialized area to prevent, diagnose, and manage heart-related issues in cancer patients. One of the leading journals in this field is JACC: CardioOncology (Journal of the American College of Cardiology: CardioOncology), which serves as a critical platform for research, education, and clinical insights.
What is JACC: CardioOncology?
JACC: CardioOncology is a peer-reviewed journal that focuses on the intersection of cardiovascular and oncology care. Published by the American College of Cardiology (ACC), the journal aims to provide the latest research findings, clinical studies, and expert opinions on managing cardiovascular diseases in cancer patients. It covers a wide range of topics, including the cardiovascular effects of cancer therapies, preventive strategies, treatment guidelines, and new developments in the diagnosis and management of heart problems related to cancer.
Why Is CardioOncology Important?
With increasing cancer survival rates due to modern treatments, there is a growing recognition of the long-term side effects of cancer therapies on cardiovascular health. Chemotherapy, radiation therapy, targeted therapies, and immunotherapy can all contribute to heart damage, increasing the risk of heart disease, heart failure, and other cardiovascular complications.
Cancer therapies may cause direct damage to the heart muscle, vascular system, or even lead to arrhythmias. These complications can appear months or even years after treatment, making early detection and ongoing monitoring essential. CardioOncology focuses on understanding these risks and developing personalized care plans to protect the cardiovascular health of cancer patients and survivors.
Key Areas of Focus in JACC: CardioOncology
-
Cardiovascular Toxicity of Cancer Treatments
Many cancer treatments, especially chemotherapy drugs like anthracyclines, and targeted therapies, can cause long-term cardiovascular damage. JACC: CardioOncology publishes studies that investigate the mechanisms of this toxicity and explore new therapies to mitigate the damage. -
Early Detection and Risk Assessment
Identifying patients at high risk for cardiovascular problems early in the treatment process is crucial. JACC: CardioOncology highlights advanced screening tools, biomarkers, and diagnostic methods to detect heart issues before they progress. -
Preventive Strategies
Prevention is a significant area of interest, and the journal provides insights into lifestyle modifications, medications, and other interventions to reduce cardiovascular risks for cancer patients. -
Management of Pre-existing Cardiovascular Disease in Cancer Patients
Many cancer patients already have cardiovascular conditions before their cancer diagnosis. Managing these patients requires a careful balance between cancer treatment and cardiovascular care, which JACC: CardioOncology aims to address. -
Long-Term Care and Survivorship
As cancer survival rates increase, so does the need for long-term cardiovascular care. Survivors may experience late-onset cardiovascular issues, making ongoing care and monitoring essential. The journal covers strategies for managing cardiovascular health in cancer survivors, ensuring they live healthy, fulfilling lives after treatment.
Scope
Cardio-oncology, a rapidly evolving field, focuses on the interplay between cardiovascular health and cancer therapies. With advances in cancer treatments, including chemotherapy, radiation, and targeted therapies, it has become increasingly essential to recognize and manage the cardiovascular side effects that can arise. The journal JACC: CardioOncology plays a pivotal role in advancing this interdisciplinary domain by providing a platform for cutting-edge research and clinical practices.
What is Cardio-Oncology?
Cardio-oncology is a specialized area that examines the cardiovascular risks and challenges faced by cancer patients, particularly those undergoing cancer treatments. Treatments like chemotherapy and radiation therapy, while effective in fighting cancer, can lead to various cardiovascular complications, including heart failure, arrhythmias, and vascular issues. The field seeks to better understand these risks, develop preventive measures, and improve the management of patients with both heart disease and cancer.
The Role of JACC: CardioOncology
JACC: CardioOncology is a peer-reviewed journal published by the American College of Cardiology (ACC). This journal serves as an essential resource for clinicians, researchers, and healthcare providers by providing a platform for the latest research, clinical guidelines, and case studies in cardio-oncology. It covers a wide range of topics within this field, including:
-
Cardiovascular Toxicity of Cancer Therapies: One of the primary focuses of the journal is the cardiovascular toxicities associated with various cancer treatments. This includes understanding the molecular mechanisms behind chemotherapy-induced cardiotoxicity, radiation-induced heart disease, and the cardiovascular effects of newer immunotherapies and targeted agents.
-
Cardiovascular Risk Assessment and Monitoring: The journal emphasizes the importance of early detection and monitoring of cardiovascular risks in cancer patients. By incorporating advanced imaging techniques and biomarkers, healthcare providers can better predict and manage cardiovascular complications in oncology patients.
-
Prevention and Management Strategies: Articles in JACC: CardioOncology provide insights into preventive measures, including lifestyle modifications, pharmacological interventions, and emerging therapies designed to mitigate the cardiovascular side effects of cancer treatments.
-
Collaborative Care Models: The journal also explores collaborative care models where cardiologists and oncologists work together to optimize patient outcomes. This multidisciplinary approach is crucial for managing patients who are undergoing complex cancer therapies and are at risk of heart-related complications.
Key Areas of Research and Focus
-
Early Detection: With the growing number of cancer survivors, there is an increasing need for early detection of cardiovascular problems that may develop years after cancer treatment. JACC: CardioOncology highlights the latest research on screening methods, including imaging and biomarkers, to detect cardiovascular issues at an early stage.
-
Personalized Treatment Approaches: Every cancer patient is unique, and so is their cardiovascular risk. The journal highlights personalized approaches to treating cardio-oncology patients, ensuring that treatments are tailored to the individual’s specific cancer therapy and cardiovascular health needs.
-
New Therapies and Innovations: Advances in cancer treatment are often accompanied by new challenges in cardio-oncology. JACC: CardioOncology features articles on innovative therapies and technologies that help mitigate the cardiovascular risks associated with newer cancer treatments.
The Future of Cardio-Oncology
As cancer survival rates continue to rise, the importance of cardio-oncology will only grow. The increasing focus on the cardiovascular side effects of cancer therapies and the development of more targeted treatments will help improve patient care and outcomes. Journals like JACC: CardioOncology will continue to be at the forefront of this exciting and essential field, providing vital insights that shape clinical practices and research in cardio-oncology.